Biocept Inc (NASDAQ:BIOC)

0.222
Delayed Data
As of Jun 22
 -0.006 / -2.63%
Today’s Change
0.17
Today|||52-Week Range
1.64
-68.01%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$15.3M

Company Description

Biocept, Inc. is an oncology laboratory service company, which focuses on the development and marketing of novel laboratory products in the detection of rare cells to include circulating tumor cells. It develops and commercializes proprietary circulating tumor cell and circulating tumor DNA tests utilizing a standard blood sample. The company utilizes cell enrichment and extraction technology for the detection and analysis of circulating tumor DNA tests. It also offers services to other laboratory testing providers, academic institutions, research organizations, biopharmaceutical companies and clinical trial support. Biocept was founded on May 12, 1997 and is headquartered in San Diego, CA.

Contact Information

Biocept, Inc.
5810 Nancy Ridge Drive
San Diego California 92121-2840
P:(858) 320-8200
Investor Relations:

Employees

Shareholders

Other institutional7.83%
Individual stakeholders5.50%
Mutual fund holders1.74%

Top Executives

Michael W. NallPresident, Chief Executive Officer & Director
Timothy C. KennedyCFO, Senior VP-Operations & Secretary
Lyle J. ArnoldChief Scientific Officer & SVP-Research
Veena M. SinghSenior Vice President & Senior Medical Director
Michael W. BrownGeneral Counsel, Compliance & Privacy Officer